Introduction: The mechanistic target of rapamycin complex 1 (mTORC1) is an evolutionarily conserved serine/threonine kinase, which regulates pivotal physiological processes. mTORC1 activity is tightly regulated upstream by the tuberous sclerosis complex (TSC) which consists of TSC1 and TSC2. In macrophages as throughout the immune system, mTORC1 is a potent regulator of cell activation and function. Myocardial infarction (MI) is associated with stimulation of mTORC1; however, studies vary as to whether this activation is beneficial or detrimental, and its influence on macrophage differentiation, and infiltration after MI is unknown. Hypothesis: We tested the hypothesis that cardiac infiltration of macrophages following MI is regulated by their expression of TSC2. Methods/Results: Macrophage-specific TSC2 knock-out mice (TSC2-LyzM) were made by crossing mice with floxed-TSC2 and LysM-Cre that display a significant reduction of macrophage TSC2 protein. TSC2-LyzM bone marrow-derived macrophages (BMDMs) have constitutive mTORC1 activation reflected by phosphorylation of downstream targets S6K1 and 4E-BP1 and were correspondingly larger. To assess macrophage polarization, cells were stimulated with LPS to promote an M1-like phenotype or IL-4 to induce an M2-like phenotype. LPS- treated TSC2-LyzM BMDMs secreted more of the proinflammatory cytokine TNF-a, while IL-4 stimulation resulted in less of an M2 program, with significantly less Arg1, Mrc1, and Rentla expression. These findings show TSC2 is required for normal BMDM polarization. We next tested if TSC2 impacts macrophage myocardial infiltration after MI. Macrophages were identified as CD45+CD11b+CD64+ and further parsed by CCR2 and MHC-II. In concordance with prior studies, we found substantial infiltration of CCR2+ (BMDMs) macrophages in both genotype groups after MI. However, more TSC2-LyzM had increased CCR2+ MHC-II+ phenotype (infiltrating macrophages) versus wild-type. Conclusion: Overall, our findings highlight a key role for the TSC2-mTORC1 pathway in regulating macrophage fate specification and cardiac infiltration following a MI. This supports novel signaling control over BMDMs by TSC2-phosphorylation mediated mTORC1 activation or inhibition.